MOLLY VALOIS: Open Payments
NPI 1598211591 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$158 in 6 payments from 4 companies in 2025. Trend: 2023 $172 · 2024 $136 · 2025 $158
Food & beverage: $158
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $75 |
| Boston Scientific Corporation | 1 | $40 |
| QOL Medical, LLC | 1 | $25 |
| Madrigal Pharmaceuticals | 1 | $18 |
Products named: RINVOQ, EXALT Model D, Sucraid, LINZESS, REZDIFFRA.
Industry payments across MD — which companies pay providers there.
